Oral theophylline benefits stable 'irreversible' chronic obstructive pulmonary disease: a systematic review and meta-analysis

F. S. F. Ram, S. Cendon (London, United Kingdom; Sau Paulo, Brazil)

Source: Annual Congress 2002 - New anti-inflammatory agents for asthma and COPD
Session: New anti-inflammatory agents for asthma and COPD
Session type: Oral Presentation
Number: 2329
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. S. F. Ram, S. Cendon (London, United Kingdom; Sau Paulo, Brazil). Oral theophylline benefits stable 'irreversible' chronic obstructive pulmonary disease: a systematic review and meta-analysis. Eur Respir J 2002; 20: Suppl. 38, 2329

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Safety and benefits of beta-blockers in chronic obstructive pulmonary disease: a review of current evidence and meta-analysis
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018

Tiotropium for the treatment of stable chronic obstructive pulmonary disease: A meta-analysis of clinically relevant outcomes
Source: Annual Congress 2010 - COPD: management
Year: 2010


Acute exacerbations of chronic obstructive pulmonary disease: current recommendations review and quality of evidence analysis.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020

Early supported discharge/hospital at home for exacerbation of chronic obstructive pulmonary disease, A review and meta-analysis
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Arm training in patients with chronic obstructive pulmonary disease: a systematic review
Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions
Year: 2009


A preliminary meta-analysis of long-term inhaled steroids for stable chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001

Mild cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: A systematic review and meta-analysis
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016

Long-term use of inhaled glucocorticoids in stable chronic obstructive pulmonary disease patients and risk of diabetes mellitus: systematic review of the literature
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018


Global burden of COPD: systematic review and meta-analysis
Source: Eur Respir J 2006; 28: 523-532
Year: 2006



Misdiagnosed COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007



Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease: A systematic review and meta-analysis
Source: International Congress 2015 – COPD: notable points
Year: 2015


²Hospital at home² versus inpatient care for patients with acute exacerbations of chronic obstructive pulmonary disease: cochrane systematic review and meta-analysis
Source: Eur Respir J 2003; 22: Suppl. 45, 445s
Year: 2003

Anti-interleukin 5 treatment in moderate to severe eosinophilic chronic obstructive pulmonary disease: a systematic review and meta-analysis
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019


Prevalence of metabolic syndrome among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Hypertension in chronic obstructive pulmonary disease (COPD): A review of current practice
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


Optimizing chronic obstructive pulmonary disease (COPD) diagnosis and management to reduce healthcare costs: Systematic review and modeling
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013


Epidemiology of chronic obstructive pulmonary disease in Brazil: a systematic review and meta-analysis
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019

The report of nationwide quality assessment in chronic obstructive pulmonary disease
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019